Table 2.
Hospital course of patients with STEMI in the year 2020 versus 2006-2019
| Parameter | 2020 (n = 726) | 2006-2019 (n = 10.226) |
|---|---|---|
| Clinical findings and treatment: | ||
| Coronary 3-vessel diseasea | 264 (37.0%)⁎⁎ | 3215 (31.7%)⁎⁎ |
| Revascularization therapy by primary PCI | 658 (90.6%) | 9201 (90.0%) |
| Door-to-balloon-time, minutes MV ± SD | 39 ± 15⁎⁎ | 45 ± 22⁎⁎ |
| Revascularization therapy by emergency CABG | 35 (4.8%) | 494 (4.8%) |
| No revascularization therapy | 33 (4.5%) | 531 (5.2%) |
| Maximum CK-levels, U/l MV ± SD | 1915 ± 3860 | 1910 ± 3075 |
| Outcome: | ||
| Reinfarction | 2 (0.3%) | 83 (0.8%) |
| Stroke | 2 (0.3%) | 55 (0.5%) |
| In-hospital cardiac arrest | 46 (6.3%)* | 481 (4.7%)* |
| Mortality | 93 (12.8%)⁎⁎ | 864 (8.4%)⁎⁎ |
⁎
p <0.05,
⁎⁎
p <0.01 between the groups.
a
In 84 patients (n = 12 in the year 2020, n = 72 in the years 2006 to 2019) patients died before coronary status could be obtained.
MV ± SD indicates mean value ± standard deviation; CK = creatine kinase; CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention.